VRTX - Vertex Pharmaceuticals, Inc.
IEX Last Trade
495.58
2.230 0.450%
Share volume: 1,809,551
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$493.35
2.23
0.45%
Summary score
46%
Profitability
67%
Dept financing
7%
Liquidity
62%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
4.42%
Return on assets
5.74%
Return on sales
42.85%
Return on invested capital
28.91%
Total debt ratio
24.37%
Debt ratio change over timeo
0.07%
Current Ratio
4.21%
Quick Ratio
4.04%
Cash Position Ratio
3.33%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1.65%
Return on assets
4.74%
Return on sales
40.61%
Return on invested capital
4.62%
Total debt ratio
23.93%
Debt ratio change over timeo
-0.22%
Current Ratio
3.52%
Quick Ratio
3.3%
Cash Position Ratio
2.7%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-24.32%
Return on assets
4.64%
Return on sales
35.34%
Return on invested capital
-47.02%
Total debt ratio
26.61%
Debt ratio change over time
0.38%
Current Ratio
2.52%
Quick Ratio
2.26%
Cash Position Ratio
1.63%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-92.03%
Return on assets
-85.47%
Return on sales
9.7%
Return on invested capital
-30.29%
Total debt ratio
7.26%
Debt ratio change over time
0.07%
Current Ratio
17.84%
Quick Ratio
17.06%
Cash Position Ratio
13.89%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 4.42% | 15.05% | 35.64% | 7.13% |
| Return on assets | 5.74% | 2.88% | 3.13% | 5.53% |
| Return on sales | 42.85% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 28.91% | 2.57% | 5.37% | 18.48% |
| Profitability | 78% | 43% | 62% | 69% |
| Total debt ratio | 24.37% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | 0.07% | 326.95% | -8.44% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 3.52% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.3% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.7% | 0.39% | 1.05% | 2.91% |
| Liquididy | 73% | 12% | 27% | 66% |
| Short-term ratios | VRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -1.65% | 13.14% | 10.88% | 4.07% |
| Return on assets | 4.74% | 2.1% | 1.54% | 3.03% |
| Return on sales | 40.61% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 4.62% | 1.95% | 2.74% | 9.55% |
| Profitability | 62% | 55% | 47% | 67% |
| Total debt ratio | 23.93% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -0.22% | 51.04% | -101.54% | 1.43% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 3.52% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.3% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.7% | 0.39% | 1.05% | 2.91% |
| Liquididy | 57% | 12% | 27% | 75% |